Cell
AssigneeAutolus Limited
InventorsShaun Cordoba, Martin Pulé, Vania Baldan, Alex Nicholson
Life of this patent
Estimating the term…
Loading patent…
AssigneeAutolus Limited
InventorsShaun Cordoba, Martin Pulé, Vania Baldan, Alex Nicholson
Estimating the term…
There is provided an effector immune cell which expresses a cell surface receptor or receptor complex which specifically binds an antigen recognition receptor of a target immune cell; which effector immune cell is engineered such that when a synapse is formed between the effector immune cell and the target immune cell, the capacity of the effector immune cell to kill the target immune cell is greater than the capacity of the target immune cell to kill the effector immune cell. There is also provided the use of such a cell in methods for treating cancer, preventing allograft rejection and GVHD.
An effector immune cell which expresses a cell surface receptor or receptor complex which specifically binds an antigen recognition receptor of a target immune cell;
2-3. (canceled)
An effector immune cell according to claim 3, which expresses:
5-6. (canceled)
An effector immune cell which expresses a cell surface receptor or receptor complex which specifically binds an antigen recognition receptor of a target immune cell;
8-9. (canceled)
12-16. (canceled)
18-24. (canceled)
A nucleic acid construct which comprises:
A kit of vectors comprising:
(canceled)
(canceled)
35-39. (canceled)
Dependencies are inferred from the claim text.